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empirically treat patients when they have 
pruritus and lesions typical of scabies 
in at least 2 places—even if there is no 
known household contact diagnosed with 
scabies, and even if the diagnosis cannot 
be confirmed by light microscopy (strength 
of recommendation [sor]: B, based on a 
single large cohort study). Also give empiric 
treatment to all sexual and household 
contacts of anyone diagnosed with scabies 
(sor: c, based on expert opinion). 
 In institutional settings such as 
hospitals, nursing homes, or residential 
facilities, treat the entire at-risk population 
empirically to prevent epidemics (sor: 
c, based on expert opinion). In hospital 
settings, give empiric treatment to health 
care workers with skin exposure to patients 
with scabies (sor: B, based on case-
control study). 
Treating empirically saves 
money (and unnecessary itching)
During my medical training and years in the 
military, I have seen patients who suffered 
prolonged itching because they had no 
microscopic confirmation of scabies, but 
who cleared quickly with treatment after 
a skin biopsy identified scabies. This 
has given me a “short fuse” for treating 
empirically in my own clinics. 
 Though I always encourage the 
residents to do a scraping—since the 
microscopic confirmation is one of those 
“oh, wow!” findings when it is positive 
(Figure)—it is reassuring to know that 
evidence exists for opting to treat without 
confirmation. It also saves the patient the 
cost of the skin scraping and microscopy—
important for the increasing numbers of 
cash-paying, uninsured patients.
 Permethrin is relatively safe (rated 
category B in pregnancy), usually 
affordable, and well-tolerated; the hardest 
part of the empiric treatment may be the 
emotional impact on the patient who is told 
his skin has a “parasitic infestation.” (I’m 
itching at the thought!)
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evidence-based answer
clinical commentary
z	evidence	summary
Clinical diagnosis of scabies begins with 
pruritus, typical lesions in a distribution 
consistent with scabies—finger webs, 
wrists, axillae, elbows, buttocks, genita-
lia of men, breasts of women—and pos-
sible exposure. Clinical diagnosis can be 
confirmed by skin scrapings from char-
acteristic lesions, such as burrows. When 
these scrapings are examined under light 
microscopy, they can show mites, eggs, or 
feces from the mites (Figure). However, 
this technique depends greatly on opera-
tor experience and skill, and a lack of 
Don’t bother with 
skin scrapings—
just treat patients 
with itching and 
typical lesions
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light microscopy findings does not rule 
out scabies.1 
The only study we found that in-
vestigated the sensitivity of clinical fea-
tures in diagnosing scabies was done in 
sub-Saharan Africa.2 In this study, the 
presence of diffuse itching, plus lesions 
in at least 2 locations typical with sca-
bies or a household member with itch, 
had 100% sensitivity and 96.9% speci-
ficity for scabies infection. This study 
used the evaluation of a dermatologist 
as a gold standard. The authors pro-
pose that treatment based on clinical 
findings with or without microscopic 
confirmation is appropriate; however, it 
is not clear how these data translate to 
a primary care population with a lower 
prevalence of scabies. 
Long	stretches	without	symptoms	
play	role	in	treatment
To date, no controlled trials address 
whether empiric treatment of asymp-
tomatic contacts or family members of 
those with scabies decreases its spread. 
However, it is known that an initial 
infestation with scabies will not lead 
to pruritus for up to 4 to 6 weeks.1 
Asymptomatic contacts can be infected 
with scabies, and can transmit this in-
fection to others before symptoms even 
occur. 
Given the long period of asymptom-
atic infestation, prevention of epidemics 
in institutions such as hospitals, nurs-
ing homes, and residential facilities is of 
particular importance. One case-control 
study, performed at a large tertiary-care 
teaching hospital, demonstrated that 
health care workers on a service having 
a patient with undiagnosed scabies were 
5.3 times more likely to develop a pru-
ritic rash than those in other units.3 
Health care workers with more 
skin-to-skin contact with the patients 
(nurses, nursing students, and physical 
therapists) were 4.5 times more likely to 
develop scabies compared with those in 
less physical contact (physicians, medi-
cal students, and occupational thera-
pists). Among the symptomatic health 
Empirically treat:
•  sexual/household 
contacts of those  
diagnosed
•  hospital health care 
workers having skin 
contact with those 
diagnosed
•  anyone at risk in a 
hospital or nursing 
home setting
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figurE
Diagnostic mineral oil scraping  
that “unroofed” the mite,  
with feces (small pellets) and  
3 ovoid eggs evident.
I always encourage residents to do 
a scraping, since the microscopic 
confirmation is one of those  
“oh, wow!” findings when it is positive.
It is reassuring to know that  
evidence exists for opting to treat 
without confirmation. It also saves  
the patient the cost of the skin  
scraping and microscopy— 
important for the increasing numbers  
of cash-paying, uninsured patients.
 —Barbara Walker, Do 
The	“Oh,	wow!”	test
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care workers, 17% of their household 
contacts developed scabies, too.
Permethrin	vs	lindane?		
Which	is	better?	
A 2000 Cochrane review, updated in 
2002, concluded that permethrin was 
superior to lindane for topical treatment 
of scabies.4,5 Combining 4 trials with 718 
patients, permethrin 5% appeared better 
than lindane 1% (odds ratio=0.66; 95% 
confidence interval, 0.46–0.95). How-
ever, there was significant heterogeneity 
between the studies, and the largest trial 
(n=467) found no difference. 
Oral ivermectin, though costly, is 
an effective alternative for those who 
do not tolerate topical treatment. See 
the TabLe for a summary of treatment 
recommendations.
recommendations	from	others
Guidelines released by the Centers for 
Disease Control and Prevention in 
2002 regarding the treatment of sexu-
ally transmitted diseases state that both 
sexual and close personal or household 
contacts of patients diagnosed with sca-
bies within the preceding month should 
be examined and treated.6
Another guideline, developed by the 
British Association of Sexual Health and 
HIV, recommends empiric treatment of 
sexual, household, and institutional con-
tacts of those with scabies. This guideline 
recommends treating those who were 
in contact with the scabies patient with-
in 2 months of his diagnosis; this time 
frame, though, is arbitrary.7 No evidence 
grading was given for these recommen-
dations, which are based on expert 
opinion.  n
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Topical permethrin 
is the preferred 
treatment. If oral 
medication is 
needed, prescribe 
ivermectin
TaBlE
recommended	treatment	for	scabies	infection
Diagnosis recommenDeD TheraPy sor
High-risk individual Permethrin 5% topical solution 
with exposure (single overnight application) A
Typical scabies infection Permethrin 5% topical solution 
 (single overnight application) A
Crusted (norwegian) scabies oral ivermectin 
 200 mcg/kg single dose repeated in 14 days B
Scabies in patient with HiV oral ivermectin 
 200 mcg/kg single dose repeated in 14 days B
Data taken from 2000 Cochrane systematic review4 and 2002 update.5 
sor, strength of recommendation.
